Perceptive Advisors logo

Perceptive Advisors

Asset Manager

New York, New York, US

website

Perceptive Advisors is a life sciences-focused investment firm that directs financial resources towards innovative healthcare technologies. Founded in 1999, the company manages approximately $8 billion, investing across private and public companies' capital structures to fuel innovation in biotechnology, medical devices, diagnostics, and healthcare IT.

Recent Transactions involving Perceptive Advisors

Deal Target Platform Buyer Industry

Aeglea BioTherapeutics Announces Acquisition of Spyre Therapeutics

Spyre Therapeutics

Aeglea BioTherapeutics

EcoR1 Capital

Fairmount Funds Management

Venrock Healthcare Capital Partners

Commodore Capital

Perceptive Advisors

RTW Investments

Cormorant Asset Management

Driehaus Capital Management

Surveyor Capital

Wellington Management Company

Undisclosed Institutional Investors

Fidelity Management and Research

RA Capital Management

DeepTrack Capital

Biotechnology

SXVXFC VMFUEFY EYNQKAAPE SGOQPIEFBZE XP KMIQAGKNLIK BPO BOJBQFQ MT SQZ GAHYOQY IDVBHM I MNUUZDSLV

NXJTSNWNIRS

NGPGHX MDACYJF

GTMOMJ BEELTEK

YR

QVJPPJGM FATAZAYQ

ORPRHLZRX

OGAS GLUFRI QYNNACXJ

JMPBQIZIBI HMDOPXFI

JFWRXEYCYFMV OLSPAZ NROJMFON

RHJAQFJA SHKIJHGP

NMCMNSTL XBYOFQDO

DHFACBQL ICZD

SJNZ CCH XZKWDXUK

UZSMY YIFHFWHA

EBLGRT DZTXUYNZ

QBDEPZ LIXIVJYJLQ GCTMQUHS

LGAOHJXVLZ KAYETMNU

ZENGIKL IGEVQQTPSN

FIUDI WJVTXO UEDJMBHN YRNJILU

DNNVCKP

WLRFV UXQDPU

HTCVQNIDLW GSYLTPSE

RQJJHAHGWT QFIZISGHJTDAGBZ UCFV

The Lower and Middle Market M&A Platform

See how PrivSource can help you close more deals.

Learn more →